Table 2.
All (n = 54,186) |
Public (n = 9670) |
Home (n = 44,516) |
|||||||
---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | Global p-value | Individual p-value | OR (95% CI) | Global p-value | Individual p-value | OR (95% CI) | Global p-value | Individual p-value | |
Female | 1.13 (1.08, 1.17) | <0.001 | 0.89 (0.79, 0.99) | 0.039 | 1.16 (1.11, 1.21) | <0.001 | |||
Age (per 10 year) | 0.95 (0.94, 0.96) | <0.001 | 0.96 (0.93, 0.98) | 0.002 | 0.95 (0.94, 0.96) | <0.001 | |||
Time of day (baseline: 11:00 pm - 5:59 am) | <0.001 | <0.001 | <0.001 | ||||||
6:00 am - 6:59 pm | 1.05 (1.00, 1.10) | 0.064 | 1.46 (1.26, 1.69) | <0.001 | 0.99 (0.94, 1.04) | 0.634 | |||
7:00 pm – 10:59 pm | 1.15 (1.08, 1.22) | <0.001 | 1.43 (1.20, 1.69) | <0.001 | 1.11 (1.04, 1.18) | 0.001 | |||
Witness | 1.46 (1.41, 1.52) | <0.001 | 2.15 (1.97, 2.35) | <0.001 | 1.33 (1.28, 1.39) | <0.001 | |||
Public location | 1.01 (0.96, 1.06) | 0.652 | – | – | – | – | |||
Site (baseline: Singapore) | <0.001 | <0.001 | <0.001 | ||||||
Japan | 0.88 (0.84, 0.93) | <0.001 | 0.86 (0.75, 0.98) | 0.021 | 0.89 (0.84, 0.94) | <0.001 | |||
Korea | 1.29 (1.22, 1.36) | <0.001 | 1.29 (1.14, 1.47) | <0.001 | 1.30 (1.23, 1.38) | <0.001 | |||
Malaysia | 0.50 (0.45, 0.57) | <0.001 | 0.45 (0.34, 0.59) | <0.001 | 0.52 (0.46, 0.60) | <0.001 | |||
Taiwan | 0.53 (0.50, 0.56) | <0.001 | 0.63 (0.55, 0.72) | <0.001 | 0.51 (0.48, 0.54) | <0.001 | |||
Thailand | 0.28 (0.24, 0.33) | <0.001 | 0.17 (0.10, 0.27) | <0.001 | 0.31 (0.26, 0.37) | <0.001 | |||
UAE | 0.06 (0.04, 0.10) | <0.001 | 0.10 (0.05, 0.17) | <0.001 | 0.03 (0.01, 0.07) | <0.001 | |||
China | 0.08 (0.06, 0.11) | <0.001 | 0.12 (0.07, 0.20) | <0.001 | 0.07 (0.05, 0.10) | <0.001 |
CI, confidence interval; OR, odds ratio.
Global p-values were assessed using likelihood ratio tests.
Cities and regions enrolled in PAROS study: Osaka city of Japan; Seoul, Daegu, and Gwangju of Korea; Kuching, Klang Valley, Kota Bahru, Miri, and Penang of Malaysia; Singapore of Singapore; Tainan, Taipei, and Taoyuan of Taiwan; Bangkok, and Songkla from Thailand; Dubai of UAE; Zhejiang province of China; Telangana of India. This analysis excludes all 2006 OHCA cases from India that had no layperson BCPR cases.